| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,000 | 0,046 | 18:42 |
| Dividendenbekanntmachungen (10.04.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADVANCE AUTO PARTS INC US00751Y1064 0,25 USD 0,2136 EUR ALM BRAND A/S DK0015250344 0,66 DKK 0,0883 EUR ALMA MEDIA OYJ FI0009013114 - 0... ► Artikel lesen |
| AT&T Receives Frost & Sullivan's 2026 US Public Safety Solutions Company of the Year Recognition for Excellence in Mission-Critical Connectivity | AT&T is recognized for advancing public safety communications through ubiquitous connectivity, innovation, and a resilient network architecture through FirstNet, Built with AT&TSAN ANTONIO... ► Artikel lesen |
| Assurant and AT&T Tree for Trade-In Program Supports Ongoing Reforestation in California Through the Arbor Day Foundation | LINCOLN, NE / ACCESS Newswire / April 2, 2026 / For a second consecutive year, Assurant, Inc. (NYSE: AIZ), a premier global protection company that safeguards and services connected devices, homes,... ► Artikel lesen |
| Weekly Buzz: MacroGenics Resumes LINNET; GSK Wins China Nod; FDA Okays Waters Corporation; Neurocrine Biosciences Snaps Up Soleno Therapeutics | THOUSAND OAKS (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals across the U.S., Canada, and China, alongside the lifting of a clinical trial hold by the FDA, collaborations... ► Artikel lesen |
| UBS stuft GSK auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für GSK mit einem Kursziel von 1940 Pence auf "Neutral" belassen. Analyst Matthew Weston geht mit moderat negativen Erwartungen... ► Artikel lesen |
| GSK Announces Approval Of Exdensur In China | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - GSK plc (GSK, GSK.L) announced that China's National Medical Products Administration has approved Exdensur or depemokimab as an add-on therapy with intranasal... ► Artikel lesen |